IQVIA Japan Thought Leadership Webinar 2020 - Outlook to 2024 and the Impact of the COVID-19 Outbreak in Japan
May 20, 2020
5:00PM - 6:00PM Eastern Daylight Time

Date: May 20, 2020

Time: 5– 6 PM EDT (Eastern Daylight Time)


The COVID-19 outbreak has had an economic and social impact on daily life – including on pharmaceutical consumption and other healthcare indicators. Join IQVIA Japan as we discuss the Japan pharmaceutical market outlook to 2024 and the impact of the COVID-19 outbreak on pharmaceutical consumption in the world's 2nd largest branded pharmaceutical market.  

Key Takeaway 

  • Receive an update on the outlook of the Japan pharmaceutical market to 2024
  • Gain insights into the impact of COVID-19 on pharmaceutical spend in Japan

Alan Thomas

Thought Leadership, IQVIA Japan Group

Alan Thomas joined IQVIA in 1999 supporting multinational pharma companies in the Japan market. In 2002 he was appointed Manager Japan Global Accounts, supporting Japanese pharma companies with sales, marketing and consulting services for Japan, Europe, USA, China and Asia Pacific. In 2004 he was appointed Global Key Account Manager and in 2006 he was appointed Global Key Account Director, a position he held until January 2011 when he was appointed Director Global Pharma Segmentation and Account Management, a role in which Alan worked with global teams to deliver expanded business intelligence and decision support to pharma companies - both Japanese and foreign multinationals. In 2012 Alan took on an expanded role supporting the wider healthcare stakeholder community. In this role Alan supported the IQVIA thought leadership and market insights initiatives globally, and strengthened Japan’s thought leadership position. In 2016 Alan was appointed Director Thought Leadership and in this role he continues to engage with the wider healthcare stakeholder community, supporting the integrated IQVIA thought leadership and market insights teams, and leading Japan’s thought leadership position.